A. Tsenga

发表

Prognostic relevance of apoptotic cell death in non‐Hodgkin's lymphomas: a multivariate survival analysis including Ki67 and p53 oncoprotein expression

C. Kittas, P. Korkolopoulou, M. Angelopoulou, 1998, Histopathology.

A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.

C. Kittas, P. Korkolopoulou, A. Tsenga, 1993, Human pathology.

Expression of c-myc p62 Protein in Non-Hodgkin's Lymphomas.

C. Kittas, P. Korkolopoulou, A. Tsenga, 1990, Leukemia & lymphoma.

The expression of the B‐cell marker mb‐1 (CD79a) in Hodgkin's disease

P. Korkolopoulou, A. Tsenga, K. Gatter, 1994, Histopathology.

Reduced retinoblastoma gene protein to Ki-67 ratio is an adverse prognostic indicator for ovarian adenocarcinoma patients.

P. Korkolopoulou, A. Tsenga, E. Patsouris, 2003, Gynecologic oncology.

Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implications

P. Korkolopoulou, M. Angelopoulou, A. Tsenga, 2005, Leukemia.

Expression of C-myc p62 oncoprotein in multiple myeloma: an immunohistochemical study of 180 cases.

C. Kittas, N. Agnantis, A. Tsenga, 1993, Anticancer research.

Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications

M. Dimopoulos, P. Korkolopoulou, A. Tsenga, 2007, British Journal of Cancer.

Her2 negative luminal breast carcinoma and Ki-67 evaluation.

A. Tsenga, K. Pavlakis, T. Vrekoussis, 2012, Breast.

Assessment of proliferating-cell nuclear antigen immunostaining in soft-tissue tumours: Relationship to histological grade and mitotic activity

A. Papanikolaou, P. Korkolopoulou, A. Tsenga, 2005, Journal of Cancer Research and Clinical Oncology.